RFK Jr. Allows Compounding Pharmacies to Sell Six Unproven Peptides Despite FDA Concerns
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Health Secretary Robert F. Kennedy overruled FDA scientists by shielding compounding pharmacies from enforcement for selling six peptides removed from an approved list in 2023 over safety concerns. The FDA says evidence of their effectiveness remains insufficient and they may be dangerous.
Continue in the app — vote & join in ➔Source: Ars Technica · via ahirlevel.hu